Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients
- 1 March 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (3) , 583-586
- https://doi.org/10.1046/j.1365-2133.2001.04088.x
Abstract
Background Mycophenolate mofetil (MMF) is a novel immunosuppressive drug. Several case reports have suggested that MMF has a beneficial effect in patients with psoriasis and autoimmune dermatoses. ...Keywords
This publication has 20 references indexed in Scilit:
- Mycophenolic acid in psoriasisBritish Journal of Dermatology, 2006
- Psoriasis vulgaris treated successfully with mycophenolate mofetilBritish Journal of Dermatology, 1998
- Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential usesJournal of the American Academy of Dermatology, 1997
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Mycophenolate MofetilDrugs, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Mycophenolic acid for psoriasisJournal of the American Academy of Dermatology, 1987
- Efficacy of mycophenolic acid for the treatment of psoriasisJournal of the American Academy of Dermatology, 1979
- Severe Psoriasis – Oral Therapy with a New RetinoidDermatology, 1978
- Treatment Of Psoriasis With Oral Mycophenolic AcidJournal of Investigative Dermatology, 1975